InvestorsHub Logo
Followers 24
Posts 2234
Boards Moderated 0
Alias Born 03/18/2013

Re: investorfreak69 post# 27197

Tuesday, 05/06/2014 4:39:56 PM

Tuesday, May 06, 2014 4:39:56 PM

Post# of 427276
Freak: Can you be a little more specific and supply some details as to why you think Amarin's (Startup Pharmaceutical) balance sheet is a joke? Let's see;
1) Amarin has the supply chain tied up for High Purity EPA
2) Amarin cash burn is approx. $70M per year, with their cash reserves somewhere around $190M.
3) You're forgetting KOWA coming on-line in May
4) Preliminary Reduce-it results we should see sometime in 2015 1st or 2nd Quarter by the latest.
5) Did I mention KOWA is coming on-line in May and is eventually going to form a partnership (IMHO)?
6) What about METFORMIN & EPA combo drug studies sponsored by KOWA?
7) Did I mention we will see increased sales through the summer? Currently $10M (Annual sales projected = $40M) per quarter and Quarter over Quarter sales will be increasing, thus off setting cash burn for Reduce-it.

I would like to see your analogy rather than just spewing "Amarin’s Balance sheet is trash". Prove to me it's trash with a logical argument. Thanks
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News